Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This phase II study will test the response rate of combined oxaliplatin and capecitabine
treatment when administered at a given dose and schedule, in patients with Head and Neck
cancer for which there is no curative treatment.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville